File photo of abortion pill. Photo/File/CBS News

The abortion pill has killed almost five million babies in the U.S. since its approval in 2000, according to updated data published by the U.S. Food and Drug Administration (FDA). And in just the past three years, two additional deaths have been attributed to the abortion pill.

Live Action reports:

The abortion pill, mifepristone (brand name Mifeprex), was approved by the FDA in 2000 for the termination of pregnancy in a regimen along with a second drug, misoprostol.

In December of 2018, the FDA reported 24 deaths associated with abortion pills since its approval but on December 16, 2021 the FDA published an updated “Post-Marketing Adverse Events Summary” revealing that as of June 30, 2021, that number has now climbed to 26. The report also tragically reveals that the “estimated number of women who have used [abortion pill] mifepristone in the U.S. for medical termination of pregnancy through the end of June 2021 is approximately 4.9 million women.”

Just last week, the Biden-Harris FDA weakened important safety regulations (REMS) on abortion pills, eliminating the in-person requirement and permanently allowing the deadly drug regimen to be shipped by mail. REMS ,Risk Evaluation and Mitigation System, is a “drug safety program that the… FDA can require for certain medications with serious safety concerns.”

The FDA wrote, “It is not uncommon for FDA to receive reports of serious adverse events for prescription drugs after they are approved. FDA has received reports of serious adverse events in women who took mifepristone. As of June 30, 2021, there were reports of 26 deaths of women associated with mifepristone since the product was approved in September 2000, including two cases of ectopic pregnancy (a pregnancy located outside the womb, such as in the fallopian tubes) resulting in death; and several cases of severe systemic infection (also called sepsis), including some that were fatal.”

Read more at Live Action

 

Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments